Accéder au contenu
Merck

Triazolyl tryptoline derivatives as β-secretase inhibitors.

Bioorganic & medicinal chemistry letters (2010-10-15)
Jutamas Jiaranaikulwanitch, Chantana Boonyarat, Valery V Fokin, Opa Vajragupta
RÉSUMÉ

Tryptoline, a core structure of ochrolifuanine E, which is a hit compound from virtual screening of the Thai herbal database against BACE1 was used as a scaffold for the design of BACE1 inhibitors. The tryptoline was linked with different side chains by 1,2,3-triazole ring readily synthesized by catalytic azide-alkyne cycloaddition reactions. Twenty two triazolyl tryptoline derivatives were synthesized and screened for the inhibitory action against BACE1. JJCA-140 was the most potent inhibitor (IC(50)=1.49 μM) and was 100 times more selective for BACE1 than for Cat-D.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole, 98%